

Cover Story
Free
By Matthew Bin Han Ong
Roche has signed an agreement to acquire all shares of Flatiron Health, a health care technology and services company headquartered in New York City, for $1.9 billion.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Trump backs off the 100% pharma tariffs ultimatum